ExLibris header image
SFX Logo
Title: Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
Source:

Cell death & Disease [2041-4889] yr:2015


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Zhu, J. "Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity." Scientific Reports 7 (2017): 11879-11879. Link to Full Text for this item Link to SFX for this item
2. Vacchi Suzzi, C. "Perturbation of microRNAs in rat heart during chronic doxorubicin treatment." PLoS ONE 7.7 (2012). Link to Full Text for this item Link to SFX for this item
3. Piegari, E. "MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat." Oncotarget 7.38 (2016): 62312-62326. Link to Full Text for this item Link to SFX for this item
4. Desai, Varsha G. "Early biomarkers of doxorubicin-induced heart injury in a mouse model." Toxicology and applied pharmacology 281.2 (2014): 221-9. Link to SFX for this item
5. Alimoradi, H. "The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin." Cardiovascular toxicology 12.4 (2012): 318-325. Link to SFX for this item
6. Hebrant, A. "Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes." Experimental cell research 318.5 (2012): 444-452. Link to SFX for this item
7. Ruggeri, C. "Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients." Heart Failure Reviews 23.1 (2018): 109-122. Link to SFX for this item
8. Saddic, Louis A. "Sarco“MiR” friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy." Annals of translational medicine 4.10 (2016): 203-203. Link to Full Text for this item Link to SFX for this item
9. Yang, Y. "New strategies for improving stem cell therapy in ischemic heart disease." Heart Failure Reviews 21.6 (2016): 737-752. Link to SFX for this item
10. Zhang, Y. "Fosinopril Attenuates the Doxorubicin-induced Cardiomyopathy by Restoring the Function of Sarcoplasmic Reticulum." Cell biochemistry and biophysics (2012): 205-211. Link to Full Text for this item Link to SFX for this item
11. Sherief, Laila M. "Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children." Hematology 17.3 (2012): 151-156. Link to SFX for this item
12. Swamy, Agadihiremath V. "Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats." Indian Journal of Pharmacology 44.1 (2012): 73-77. Link to Full Text for this item Link to SFX for this item
13. Consonni, Sarah V. "cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membrane." Proceedings of the National Academy of Sciences of the United States of America 109.10 (2012): 3814-3819. Link to Full Text for this item Link to SFX for this item
14. Schwaninger, W. "Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia." The journal of neuroscience 26.50 (2006): 12896-903. Link to Full Text for this item Link to SFX for this item
15. Zernecke, A. "Chemokines in atherosclerosis: an update." Arteriosclerosis, thrombosis, and vascular biology 28.11 (2008): 1897-908. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced